The AAHP Summit: Implementing HPUS Guidelines for FDA Compliance

AAHP is committed to advancing quality and safety throughout the homeopathic industry. That’s why we’re pleased to offer a free summary slide deck of this year’s Summit presentations. The Sept. 23, 2020 virtual event was packed with must-know insights and resources to help you keep compliant with FDA guidelines. Explore the Summit content, including:

• Keynote speaker Francis Godwin, MBA, Director, FDA Office of Manufacturing Quality, Office of Compliance, reviews trends in FDA inspections of homeopathic drug manufacturers.
• Emily N. Babik, Ph.D., Vice President, Research & Development, Hyland’s Inc., a division of Standard Homeopathic Co., offers an overview of the five technical gaps that challenge both industry and FDA investigators during inspections.
• Adam W. Grobin, Ph.D., Independent Consultant, has tackled the first of the gaps — and presents a guideline for validating dilution processes when manufacturers prepare Hahnemannian liquids.

View the free presentation summary here.

A complete recording of the AAHP Summit: Implementing HPUS Guidelines for FDA Compliance, as well as four full PowerPoint slide decks from presenters, are available for purchase below.